330 related articles for article (PubMed ID: 11862188)
21. [NK-cell lymphomas and NK-like T-cell lymphomas].
Oshimi K
Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases.
Miyamoto T; Yoshino T; Takehisa T; Hagari Y; Mihara M
Br J Dermatol; 1998 Sep; 139(3):481-7. PubMed ID: 9767295
[TBL] [Abstract][Full Text] [Related]
23. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
[TBL] [Abstract][Full Text] [Related]
24. CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizations.
Paulli M; Boveri E; Rosso R; Aricò M; Kindl S; Viglio A; Berti E; Leithäuser F; Locatelli F; Gianelli U; Beluffi G; Feller AC; Borroni G; Magrini U
Am J Dermatopathol; 1997 Aug; 19(4):384-90. PubMed ID: 9261474
[TBL] [Abstract][Full Text] [Related]
25. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature.
Stokkermans-Dubois J; Jouary T; Vergier B; Delaunay MM; Taieb A
Dermatology; 2006; 213(4):345-9. PubMed ID: 17135744
[TBL] [Abstract][Full Text] [Related]
26. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh.
Pol-Rodriguez MM; Fox LP; Sulis ML; Miller IJ; Garzon MC
J Am Acad Dermatol; 2006 May; 54(5 Suppl):S192-7. PubMed ID: 16631938
[TBL] [Abstract][Full Text] [Related]
27. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Lan MX; Zhen ZX; Ming WH
Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
[No Abstract] [Full Text] [Related]
28. Extranodal natural killer cell/t-cell lymphoma, nasal type, presenting as cutaneous nodules and a small-bowel perforation.
Agarwal P; Ruzinova MB; Harris MH; Qureshi AA; Stebbins WG
Am J Dermatopathol; 2010 Feb; 32(1):83-5. PubMed ID: 19940752
[TBL] [Abstract][Full Text] [Related]
29. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas.
Tsang WY; Chan JK; Ng CS; Pau MY
Am J Surg Pathol; 1996 Feb; 20(2):202-10. PubMed ID: 8554110
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous intravascular natural killer-cell lymphoma: a case report and review of the literature.
Liu Y; Zhang W; An J; Li H; Liu S
Am J Clin Pathol; 2014 Aug; 142(2):243-7. PubMed ID: 25015867
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
32. Blastoid NK cell leukemia/lymphoma with cutaneous involvement.
Ginarte M; Abalde MT; Peteiro C; Fraga M; Alonso N; Toribio J
Dermatology; 2000; 201(3):268-71. PubMed ID: 11096204
[TBL] [Abstract][Full Text] [Related]
33. Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas.
Chang SE; Yoon GS; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):163-70. PubMed ID: 12051636
[TBL] [Abstract][Full Text] [Related]
34. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W
J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases.
Natkunam Y; Warnke RA; Haghighi B; Su LD; Le Boit PE; Kim YH; Kohler S
J Cutan Pathol; 2000 Sep; 27(8):392-9. PubMed ID: 10955685
[TBL] [Abstract][Full Text] [Related]
36. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases.
Natkunam Y; Smoller BR; Zehnder JL; Dorfman RF; Warnke RA
Am J Surg Pathol; 1999 May; 23(5):571-81. PubMed ID: 10328090
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
38. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC).
Petrella T; Dalac S; Maynadié M; Mugneret F; Thomine E; Courville P; Joly P; Lenormand B; Arnould L; Wechsler J; Bagot M; Rieux C; Bosq J; Avril MF; Bernheim A; Molina T; Devidas A; Delfau-Larue MH; Gaulard P; Lambert D
Am J Surg Pathol; 1999 Feb; 23(2):137-46. PubMed ID: 9989839
[TBL] [Abstract][Full Text] [Related]
40. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
Br J Dermatol; 2015 Jul; 173(1):134-45. PubMed ID: 25556641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
